Human umbilical cord blood cell therapy blocks the morphological change and recruitment of CD11b‐expressing, isolectin‐binding proinflammatory cells after middle cerebral artery occlusion
- 8 December 2009
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 88 (6) , 1213-1222
Abstract
Secondary neurodegeneration resulting from stroke is mediated by delayed proinflammatory signaling and immune cell activation. Although it remains unknown which cell surface markers signify a proinflammatory phenotype, increased isolectin binding occurs on CD11b‐expressing immune cells within injured brain tissue. Several reports have confirmed the efficacy of human umbilical cord blood (HUCB) cell therapy in reducing ischemic injury in rat after middle cerebral artery occlusion (MCAO), and these effects were attributed in part to dampened neuroinflammation. The present study examined the time course of lectin binding to cells of microglia/macrophage lineage within 96 hr after MCAO and whether delayed HUCB cell treatment alters the migration and/or morphological characteristics of these cells throughout the period of infarct expansion. Isolectin binding was up‐regulated in response to injury, was maximal at 96 hr, and colocalized with cells that expressed the putative proinflammatory markers MMP‐9 and nitric oxide. Isolectin‐tagged fluorescence was also significantly increased at 72 hr and localized to greater numbers of amoeboid, CD11b‐expressing cells relative to 51 hr. Treatment with 1 × 106 HUCB cells significantly reduced total lectin binding at 72 hr, as well as the total area occupied by lectin‐tagged fluorescence at both 51 and 72 hr, relative to vehicle‐treated controls. This effect was accompanied by a shift in the morphology of CD11b‐positive cells from amoeboid to ramified shape. These data indicate that HUCB cell therapy suppressed the recruitment of proinflammatory, isolectin‐binding cells during the period of infarct expansion, thus offering a potential mechanism for the protective effects of HUCB cell therapy.Keywords
This publication has 28 references indexed in Scilit:
- Blockade of adrenoreceptors inhibits the splenic response to strokeExperimental Neurology, 2009
- Inhibition of gelatinase activity reduces neural injury in an ex vivo model of hypoxia–ischemiaNeuroscience, 2009
- Sigma receptors suppress multiple aspects of microglial activationGlia, 2008
- Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 releaseJournal of Leukocyte Biology, 2008
- The spleen contributes to stroke‐induced neurodegenerationJournal of Neuroscience Research, 2008
- Timing of Cord Blood Treatment after Experimental Stroke Determines Therapeutic EfficacyCell Transplantation, 2006
- BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic painNature, 2005
- Cytokines and acute neurodegenerationNature Reviews Neuroscience, 2001
- Reperfusion Injury after Focal Cerebral Ischemia: The Role Inflammation and the The rapeutic HorizonNeurosurgery, 1998
- Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion.Stroke, 1994